These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23357672)

  • 1. Repercussions of occult malignancy - an etiologic basis for rheumatic disease.
    Johnson AK
    Med Hypotheses; 2013 Apr; 80(4):447-51. PubMed ID: 23357672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Paraneoplastic autoimmune disorders].
    Hirokawa M
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):980-3. PubMed ID: 20567097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies.
    Abu-Shakra M; Buskila D; Ehrenfeld M; Conrad K; Shoenfeld Y
    Ann Rheum Dis; 2001 May; 60(5):433-41. PubMed ID: 11302861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignancy dominated with rheumatic manifestations: A retrospective single-center analysis.
    Wen J; Ouyang H; Yang R; Bo L; Zhang Y; Tang M; Liu Z
    Sci Rep; 2018 Jan; 8(1):1786. PubMed ID: 29379092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancies and soluble tumor antigens in rheumatic diseases.
    Szekanecz E; András C; Sándor Z; Antal-Szalmás P; Szántó J; Tamási L; Kiss E; Szekanecz Z
    Autoimmun Rev; 2006 Nov; 6(1):42-7. PubMed ID: 17110316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatic syndromes: clues to occult neoplasia.
    Naschitz JE; Rosner I; Rozenbaum M; Zuckerman E; Yeshurun D
    Semin Arthritis Rheum; 1999 Aug; 29(1):43-55. PubMed ID: 10468414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheumatology and oncology: an updated review of rheumatic manifestations of malignancy and anti-neoplastictherapy.
    Alias A; Rodriguez EJ; Bateman HE; Sterrett AG; Valeriano-Marcet J
    Bull NYU Hosp Jt Dis; 2012; 70(2):109-14. PubMed ID: 22892000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gastrointestinal tumors. Clinical manifestations of paraneoplastic rheumatic symptoms].
    Mayet WJ
    Z Rheumatol; 2011 Sep; 70(7):567-72. PubMed ID: 21858488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leukocyte antigens class II genes are associated with cancer development in the autoimmune rheumatic diseases.
    Miranda-Duarte A; Kraus-Weisman A; Granados J; Vill AR
    Rev Invest Clin; 2011; 63(3):236-43. PubMed ID: 21888287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cytokines in the pathogenesis of autoimmune processes in some rheumatic diseases.
    Matei I
    Roum Arch Microbiol Immunol; 1993; 52(3):157-64. PubMed ID: 7833529
    [No Abstract]   [Full Text] [Related]  

  • 11. Musculoskeletal syndromes associated with malignancy (excluding hypertrophic osteoarthropathy).
    Naschitz JE; Rosner I
    Curr Opin Rheumatol; 2008 Jan; 20(1):100-5. PubMed ID: 18281865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature Part 4: Neurological paraneoplastic syndromes, involving the peripheral nervous system and the neuromuscular junction and muscles.
    Ruelle L; Bentea G; Sideris S; El Koulali M; Holbrechts S; Lafitte JJ; Grigoriu B; Sculier C; Meert AP; Durieux V; Berghmans T; Sculier JP
    Lung Cancer; 2017 Sep; 111():150-163. PubMed ID: 28838388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 5: Neurological auto-antibodies, discussion, flow chart, conclusions.
    Sculier C; Bentea G; Ruelle L; Grigoriu B; Coureau M; Gorham J; Sideris S; Holbrechts S; Lafitte JJ; Meert AP; Durieux V; Berghmans T; Sculier JP
    Lung Cancer; 2017 Sep; 111():164-175. PubMed ID: 28838389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic rheumatologic syndromes.
    Azar L; Khasnis A
    Curr Opin Rheumatol; 2013 Jan; 25(1):44-9. PubMed ID: 23026875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulatory T cells and rheumatic diseases].
    Humrich JY; Kamradt T; Riemekasten G
    Z Rheumatol; 2015 Feb; 74(1):26-32. PubMed ID: 25676125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatic paraneoplastic syndromes - A clinical link between malignancy and autoimmunity.
    Manger B; Schett G
    Clin Immunol; 2018 Jan; 186():67-70. PubMed ID: 28736272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatic syndromes: clues to occult neoplasia.
    Naschitz JE
    Curr Opin Rheumatol; 2001 Jan; 13(1):62-6. PubMed ID: 11148717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatic manifestations of cancer.
    Ashouri JF; Daikh DI
    Rheum Dis Clin North Am; 2011 Nov; 37(4):489-505. PubMed ID: 22075194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BAFF/APRIL system: an important player in systemic rheumatic diseases.
    Mackay F; Sierro F; Grey ST; Gordon TP
    Curr Dir Autoimmun; 2005; 8():243-65. PubMed ID: 15564724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pursuing an occult carcinoma in a patient with subacute cerebellar degeneration and anticerebellar antibodies. Need for vigorous follow-up.
    Greenlee JE; Brashear HR; Jaeckle KA; Geleris A; Jordan K
    West J Med; 1992 Feb; 156(2):199-202. PubMed ID: 1536083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.